Syndromic Surveillance 2.0: Emerging Global Surveillance Strategies for Infectious Disease Epidemics
RAND Health Quarterly, 2023; 11(1):8
RAND Health Quarterly, 2023; 11(1):8
RAND Health Quarterly is an online-only journal dedicated to showcasing the breadth of health research and policy analysis conducted RAND-wide.
More in this issueThe U.S. Army has a long history of preventing, detecting, and treating infectious diseases. Like other organizations and agencies involved in public health, the Army is increasingly interested in syndromic surveillance strategies—those designed to identify outbreaks before clinical data are available. Researchers use various methods to identify surveillance strategies across the globe, investigate these strategies' benefits and limitations, and recommend actions to aid the Army in their efforts to detect emerging epidemics and pandemics.
The research reported here was completed in June 2022, followed by security review by the sponsor and the U.S. Army Office of the Chief of Public Affairs, with final sign-off in August 2023.
The U.S. Army has a long history of preventing, detecting, and treating infectious diseases for American and allied forces and, by extension, protecting populations worldwide. Like other organizations and agencies involved in public health, the Army is increasingly interested in syndromic surveillance strategies—those that are designed “to identify illness clusters early, before diagnoses are confirmed and reported to public health agencies, and to mobilize a rapid response, thereby reducing morbidity and mortality” (Henning, 2004).
The Army asked the RAND Corporation's Arroyo Center to research how the next generation of epidemic surveillance strategies could identify emerging epidemics and pandemics in the near and far future. We focused this task to investigating how new strategies might be used to gain early insights into emerging epidemics across the globe.
This study synthesizes information from multiple sources, including data from:
We created a three-phase epidemic surveillance framework to categorize the strategies used to conduct syndromic surveillance of infectious diseases. The phases are:
Across these phases, several factors might directly relate to the benefits and limitations of specific syndromic surveillance strategies. We categorized these factors as:
Table 1 lists the strategies for syndromic surveillance identified across the three epidemic phases.
Strategy | Benefits | Limitations | Private-Sector Enterprises |
---|---|---|---|
Phase 1—Strategies for surveilling the potential emergence of an outbreak | |||
Veterinary public health surveillance: surveillance in animal populations to detect known and novel zoonotic diseases to prevent a spillover event |
|
|
|
Remote sensing: use of satellite imagery to track environmental (e.g., rising sea levels, forest fires) or socioecological (e.g., urbanization) drivers of infection |
|
|
|
Phase 2—Strategies for surveilling for the presence of an outbreak | |||
Surveys: high frequency, geographically disaggregated indicators (e.g., self-reports of symptoms, symptom severity, and/or risk and protective behaviors) to capture the severity of the outbreak |
|
|
|
Web searches: tracking internet search terms to detect new or emerging disease outbreaks or disease symptoms, or to track the course of an outbreak |
|
|
|
Social media mentions: tracking mentions of diseases and/or symptoms on social media platforms |
|
|
|
Media monitoring and web scraping: algorithms that scan electronic news sources for indicators of confirmed or potential outbreaks |
|
|
|
Pharmaceutical sales: examining the trends in over-the-counter (OTC) drug sale data, which measures consumers’ purchasing immediately upon recognizing symptoms |
|
|
|
School and work absences: tracking absences from school and from work |
|
|
|
Data collection by health care staff: health care workers and/or administrative staff report prespecified surveillance data (e.g., temperatures or respiratory symptoms) in health care or other high-risk settings (e.g., postdisaster) |
|
|
|
Consumer expenditure data: examining trends in consumer expenditures to measure and map the extent of an outbreak |
|
|
None identified |
Geospatial techniques: use of user-supplied or automated geographic information system data to identify geographic concentrations of disease risk and map epidemic emergence and spread |
|
|
|
Wastewater sampling: collecting and testing municipal wastewater |
|
|
|
Phase 3—Strategies for tracking the extent of or potential for geographic disease spread | |||
Population movement indicators: tracking day-to-day population mobility, mass migrations, and/or gatherings among displaced populations or those gathering for cultural |
|
|
|
The syndromic surveillance strategies listed above are already in use in some surveillance systems or could be added to these systems in the future. We identified the following U.S. Department of Defense (DoD) surveillance systems currently in use:
In addition, the following systems were mentioned routinely in our literature review and/or our interviews:
Interviewees reported on a variety of factors that might influence the strategies available for outbreak surveillance. There were many issues related to the data that are used, including the quality, biases, availability, and the ways that data are presented to consumers. Interviewees also noted the importance of evaluating systems to ensure that they yield accurate and useful information. They discussed the challenge of data silos—wherein systems for detecting one disease could be used for other diseases, but, according to one interviewee, “people only look for what they're funded to look for.” Interviewees also discussed leaders’ political will for surveilling for and reporting on outbreaks and how the culture of a region or community influences its surveillance capabilities. Western approaches are viewed as myopic in this regard, particularly if they rely on individuals to report illness or seek out care in traditional health care settings. Finally, experts consistently said that one of the key problems with syndromic surveillance is not the lack of systems but ensuring those who need the systems are able to access them and support upgrades and developments that improve the systems for future use.
Our interviews with representatives with DoD suggested uneven knowledge about or access to surveillance systems—different commands prioritize different strategies to retrieve information about disease threats—and some described syndromic surveillance activities as a “patchwork” approach. We were told that, to support the combatant command (CCMD), the Defense Health Agency's Armed Forces Health Surveillance Division is working to establish an improved biosurveillance hub that incorporates existing capabilities to eventually streamline the number of systems, but this is a new effort as of this writing.
Recommendation 1. The Army should track academic and private enterprise efforts to detect diseases during the outbreak phase of epidemic surveillance. Because there is so much activity in this domain—activity that we assume will grow in the context of the coronavirus disease 2019 pandemic—the Army should continue to monitor progress but not necessarily invest in additional methods above and beyond its current investments in GEIS, DSRi, DMSS, and ESSENCE.
Recommendation 2. The Army should establish more routine training to aid general medical officers in identifying and obtaining credible data and analyzing and interpreting the data. Our interviews with defense agency and CCMD representatives revealed that, although numerous systems exist to help CCMDs and services track possible disease outbreaks, there appears to be uneven awareness among some military medical personnel regarding what systems and information they can—or should—use for this purpose.
Recommendation 3. The Army should consider investing in surveillance efforts that detect the possible emergence of an epidemic for use during the emergence phase of epidemic surveillance. Detecting viruses in animal populations is crucial to understanding the risk to humans at the human-animal interface, where most spillover events occur. The Army Veterinary Corps might be exceptionally well positioned to create or complement existing global veterinary public health surveillance efforts in support of the operational force. The Army might also be able to contribute to science or systems that apply remote sensing strategies to identify where environmental changes could increase risk for the emergence of an outbreak. Currently, human health outbreak monitoring is anchored in the MHS and might pick up only threats warranting medical attention. Investment in the emergence phase might be more predictive and reduce risk.
Recommendation 4. The Army should consider investing in surveillance efforts that detect the confirmed or potential geographic spread of an outbreak for use during the spread phase of epidemic surveillance. If the Army has or can negotiate direct access to data on population movement, it might be able to contribute to modeling the potential for disease spread globally.
Recommendation 5. The Army should leverage opportunities to engage in regional and international dialogues, where appropriate, to enhance coordination and information-sharing. The Army should seek to inform or participate in engagements with foreign partners led by civilian counterparts in the U.S. Department of State, U.S. Agency for International Development, or U.S. Centers for Disease Control and Prevention, for example. In addition, military-to-military engagements led by CCMDs or defense agencies also provide opportunities for Army personnel to become better integrated into discussions regarding data sharing and integration.
Recommendation 6. The Army should sustain, maintain, and update current disease surveillance efforts and encourage the same investment throughout DoD. Current Army surveillance efforts are exemplified by GEIS, DMSS, DSRi, and ESSENCE. Sustaining, maintaining, and updating DoD systems and additional resources for syndromic surveillance can help mitigate risks to all the armed forces, not just the U.S. Army.
The research described in this article was sponsored by the U.S. Army Office of the Surgeon General and conducted by the Personnel, Training, and Health Program within the RAND Arroyo Center.
More in this issueHenning, K. J., "What Is Syndromic Surveillance?" MMWR Supplements, Vol. 53, September 2004.
RAND Health Quarterly is produced by the RAND Corporation. ISSN 2162-8254.
Explore RAND Health Quarterly articles on PubMed